help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terpe, H. J.
Right arrow Articles by Gunthert, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terpe, H. J.
Right arrow Articles by Gunthert, U.

American Journal of Pathology, Vol 148, 453-463, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation

HJ Terpe, S Storkel, U Zimmer, V Anquez, C Fischer, K Pantel and U Gunthert
Zentrum fur Pathologie, Justus-Liebig-Universitat, Giessen, Germany.

CD44 isoforms have been implicated in tumor progression and embryogenesis. Primary renal cell tumors (n = 100) of various histopathological differentiation and grading stages were analyzed for expression of CD44 isoforms in comparison with nonmalignant adult and fetal renal tissues. Evaluations were performed by immunohistochemistry using CD44 isoform-specific monoclonal antibodies and by reverse transcriptase polymerase chain reactions (RT-PCR). In the nonmalignant kidney no CD44 variant isoforms were detected. There was a significant increase in expression of CD44 standard (CD44s) and several variant isoforms (CD44v) in the course of tumor differentiation in clear cell carcinomas (n = 68) from stages G1 to G3 (P < 0.0001 for CD44s and isoforms containing CD44-6v, and P < 0.007 for those containing CD44- 9v). Also, in chromophilic cell carcinomas (n = 13), CD44 isoform expression correlated with grading; ie, no CD44 expression was detected in G1 tumors, whereas in approximately 50% of the G2 tumors, CD44s, CD44-6v, and CD44-9v isoforms were present. Oncocytomas (n = 8), which are benign renal cell tumors, did not express CD44 isoforms, whereas invasive chromophobe cell carcinomas (n = 11) were positive for CD44s and CD44v isoforms. Transcript analyses by RT-PCR revealed that the upregulated isoforms in the carcinoma cells contained exons 8 to 10 and 3, 8 to 10 in combination from the variant region. In conclusion, expression of variant CD44 isoforms was strongly correlated with grading and appears to mediate a more aggressive phenotype to renal cell tumors.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. J. P. Lewington, B. J. Padanilam, D. R. Martin, and M. R. Hammerman
Expression of CD44 in kidney after acute ischemic injury in rats
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R247 - R254.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
V. Toma, D. Hauri, U. Schmid, D. Ackermann, R. Maurer, G. Alund, H. Knonagel, M. Rist, T. C. Gasser, G. Sauter, et al.
Focal Loss of CD44 Variant Protein Expression is Related to Recurrence in Superficial Bladder Carcinoma
Am. J. Pathol., November 1, 1999; 155(5): 1427 - 1432.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Schmits, J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al.
CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity
Blood, September 15, 1997; 90(6): 2217 - 2233.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.